Cresco Labs Inc.
CL
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 164.91M | 166.12M | 163.26M | 174.42M | 179.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 164.91M | 166.12M | 163.26M | 174.42M | 179.78M |
| Cost of Revenue | 85.55M | 80.37M | 87.13M | 91.88M | 86.35M |
| Gross Profit | 79.36M | 85.75M | 76.14M | 82.54M | 93.44M |
| SG&A Expenses | 53.53M | 55.92M | 57.39M | 55.33M | 59.07M |
| Depreciation & Amortization | 5.64M | 4.42M | 5.16M | 5.46M | 5.70M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 144.72M | 140.71M | 149.67M | 152.67M | 151.12M |
| Operating Income | 20.19M | 25.41M | 13.59M | 21.75M | 28.66M |
| Income Before Tax | -10.10M | 2.74M | -918.00K | 3.06M | 11.32M |
| Income Tax Expenses | 11.87M | 16.64M | 14.32M | 2.62M | 19.02M |
| Earnings from Continuing Operations | -21.97M | -13.89M | -15.23M | 439.00K | -7.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.91M | -2.44M | 802.00K | -4.81M | -2.85M |
| Net Income | -17.05M | -16.33M | -14.43M | -4.37M | -10.54M |
| EBIT | 20.19M | 25.41M | 13.59M | 21.75M | 28.66M |
| EBITDA | 33.05M | 37.60M | 26.50M | 35.65M | 43.59M |
| EPS Basic | -0.05 | -0.05 | -0.04 | -0.01 | -0.03 |
| Normalized Basic EPS | 0.03 | 0.02 | 0.00 | -0.01 | 0.02 |
| EPS Diluted | -0.05 | -0.05 | -0.04 | -0.01 | -0.03 |
| Normalized Diluted EPS | 0.03 | 0.02 | 0.00 | -0.01 | 0.02 |
| Average Basic Shares Outstanding | 355.54M | 354.35M | 350.24M | 347.94M | 347.36M |
| Average Diluted Shares Outstanding | 355.54M | 354.35M | 350.24M | 347.94M | 347.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |